Pieris Pharmaceuticals, Inc. (PIRS): Price and Financial Metrics
PIRS Price/Volume Stats
| Current price | $13.60 | 52-week high | $22.32 |
| Prev. close | $16.13 | 52-week low | $6.20 |
| Day low | $13.26 | Volume | 51,700 |
| Day high | $15.35 | Avg. volume | 45,988 |
| 50-day MA | $16.45 | Dividend yield | N/A |
| 200-day MA | $14.06 | Market Cap | 17.95M |
PIRS Stock Price Chart Interactive Chart >
Pieris Pharmaceuticals, Inc. (PIRS) Company Bio
Pieris Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, discovers and develops Anticalin-based drugs. The company develops Anticalin proteins that are low molecular-weight therapeutic proteins derived from lipocalins, which are naturally occurring low-molecular weight human proteins found in blood plasma and other bodily fluids. The company is based in Boston, Massachusetts.
PIRS Latest News Stream
| Event/Time | News Detail | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
PIRS Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | -16.72% |
| 1-year | 32.30% |
| 3-year | 651.38% |
| 5-year | 307.19% |
| YTD | N/A |
| 2024 | 0.00% |
| 2023 | -82.50% |
| 2022 | -72.49% |
| 2021 | 51.20% |
| 2020 | -30.94% |